StockData
Clearmind Medicine Inc. logo

Clearmind Medicine Inc. (CMND) stock

CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$4.18−0.35 (-7.67%)

Close on Nov 16, 2026Market cap $661.18KP/E –Yield –

Clearmind Medicine cash

Cash and short-term investments held at the end of each period.

Clearmind Medicine's cash was $12.04M at Jul 31, 2026. For fiscal 2025 it was $3.92M, down 40.3% from the year before. The highest annual figure on record is $6.57M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Oct 31, 2025$3.92M-40.3%
FY2024Oct 31, 2024$6.57M+21.1%
FY2023Oct 31, 2023$5.43M+4114.8%
FY2022Oct 31, 2022$128.78K-96.2%
FY2021Oct 31, 2021$3.37M+1294.4%
FY2020Oct 31, 2020$241.66K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jul 31, 2026$12.04M+244.3%
Q2 FY2026CQ1 2026Apr 30, 2026$11.42M+155.2%
Q1 FY2026CQ4 2025Jan 31, 2026$9.26M+60.1%
Q4 FY2025CQ3 2025Oct 31, 2025$3.92M-40.3%
Q3 FY2025CQ2 2025Jul 31, 2025$3.50M-54.5%
Q2 FY2025CQ1 2025Apr 30, 2025$4.47M-46.2%
Q1 FY2025CQ4 2024Jan 31, 2025$5.78M-37.7%
Q4 FY2024CQ3 2024Oct 31, 2024$6.57M+21.1%
Q3 FY2024CQ2 2024Jul 31, 2024$7.68M+99.6%
Q2 FY2024CQ1 2024Apr 30, 2024$8.31M+58.3%
Q1 FY2024CQ4 2023Jan 31, 2024$9.29M+175.6%
Q4 FY2023CQ3 2023Oct 31, 2023$5.43M+4114.8%
Q3 FY2023CQ2 2023Jul 31, 2023$3.85M+14.2%
Q2 FY2023CQ1 2023Apr 30, 2023$5.25M+2070.7%
Q1 FY2023CQ4 2022Jan 31, 2023$3.37M–
Q4 FY2022CQ3 2022Oct 31, 2022$128.78K–
Q4 FY2021CQ3 2021Oct 31, 2021$3.37M–
Q4 FY2020CQ3 2020Oct 31, 2020$241.66K–

More Clearmind Medicine figures

See a number that looks wrong?